TGFB1 and systemic sclerosis: Specifically, we demonstrated that PESV could inhibit SSc-ILD-induced EMT and alleviate pulmonary inflammation and interstitial fibrosis in model mice by the intervention of the TGF-β1/Smad signaling pathway.